Must beg to differ

Thomas Albini*, Natalia F. Callaway, Glenn J. Jaffe, William Feuer, Janet Davis, Debra Goldstein, Careen Lowder, Phoebe Lin, Quan Nguyen, Sunil Srivastava, David Callanan, Anat Galor, Raquel Goldhardt, Harry Flynn

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

The authors provide a significant interpretation of the National Eye Institute-sponsored Multicenter Uveitis Steroid Treatment study, in which patients with severe, non-infectious intermediate, posterior, or panuveitis were randomly assigned to receive local treatment using the sutured intravitreal fluocinolone acetonide implant or systemic treatment consisting of oral steroids and conventional steroid-sparing immunosuppression, with a primary outcome of visual acuity at 2 years of follow-up. The authors also present evidence-based guidance for the treatment of noninfectious posterior segment involving uveitis.

Original languageEnglish (US)
Pages (from-to)266-268
Number of pages3
JournalOphthalmic Surgery Lasers and Imaging Retina
Volume50
Issue number5
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Fingerprint Dive into the research topics of 'Must beg to differ'. Together they form a unique fingerprint.

Cite this